Fluoxetina (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Fluoxetina" in Italian language version.

refsWebsite

Global rank Italian rank

23doi.org

2^nd place

7^th place

19nih.gov

4^th place

9^th place

13oadoi.org

799^th place

22^nd place

8worldcat.org

5^th place

26^th place

7unibo.it

4,963^rd place

325^th place

2web.archive.org

1^st place

2guidetopharmacology.org

low place

1webcitation.org

24^th place

48^th place

1lilly.com

low place

1europepmc.org

8,929^th place

5,423^rd place

1nhs.uk

1,989^th place

3,151^st place

1medicinescomplete.com

low place

1jad-journal.com

low place

1jaacap.com

low place

1springer.de

low place

1aspetjournals.org

6,663^rd place

5,217^th place

1nature.com

234^th place

226^th place

aspetjournals.org

jpet.aspetjournals.org

Robinson RT, Drafts BC, Fisher JL, Fluoxetine increases GABA(A) receptor activity through a novel modulatory site, in J. Pharmacol. Exp. Ther., vol. 304, n. 3, 2003, pp. 978–84, DOI:10.1124/jpet.102.044834, PMID 12604672.

doi.org

dx.doi.org

A. L. Montejo-González, G. Llorca e J. A. Izquierdo, SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients, in Journal of Sex & Marital Therapy, vol. 23, n. 3, 1º gennaio 1997, pp. 176–194, DOI:10.1080/00926239708403923. URL consultato il 13 dicembre 2016.
Gülseren et al. (EN) Leyla Gülseren, Seref Gülseren, Zeliha Hekimsoy, Levent Mete, Comparison of Fluoxetine and Paroxetine in Type II Diabetes Mellitus Patients, in Archives of Medical Research, vol. 36, n. 2, Città del Messico, Instituto Mexicano del Seguro Social, 4 marzo 2005, pp. 159-65, DOI:10.1016/j.arcmed.2004.12.018, ISSN 0188-4409 (WC · ACNP).
Sansone et al. (EN) Randy A. Sansone, Lori A. Sansone, Sertraline-induced Hyperglycemia: Case Report, in The International Journal of Psychiatry in Medicine, vol. 33, n. 1, Amityville, Baywood Publishing Company, Inc., marzo 2003, pp. 103-5, DOI:10.2190/L2M6-Y6XT-KR7U-CAVT, ISSN 0091-2174 (WC · ACNP), PMID 12906348.
Kirby et al. (EN) Dianne Kirby, Susan Harrigan, David Ames, Hyponatraemia in Elderly Psychiatric Patients Treated with Selective Serotonin Reuptake Inhibitors and Venlafaxine: A Retrospective Controlled Study in an Inpatient Unit, in International Journal of Geriatric Psychiatry, vol. 17, n. 3, Hoboken, John Wiley & Sons Ltd, marzo 2002, pp. 231-37, DOI:10.1002/gps.591, ISSN 1099-1166 (WC · ACNP).
Malm et al. (EN) Heli Malm, Timo Klaukka, Pertti J. Neuvonen, Risks Associated With Selective Serotonin Reuptake Inhibitors in Pregnancy, in Obstetrics & Gynecology, vol. 106, n. 6, Hagerstown, Lippincott Williams & Wilkins, dicembre 2005, pp. 1289-96, DOI:10.1097/01.AOG.0000187302.61812.53, ISSN 0029-7844 (WC · ACNP), PMID 16319254.
Chambers et al. (EN) Christina D. Chambers et al., Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn, in The New England Journal of Medicine, vol. 354, n. 6, Waltham, Massachusetts Medical Society, 9 febbraio 2006, pp. 579-87, DOI:10.1056/NEJMoa052744, ISSN 0028-4793 (WC · ACNP), PMID 16467545.
Mills. (EN) James L. Mills, Depressing Observations on the Use of Selective Serotonin-Reuptake Inhibitors during Pregnancy, in The New England Journal of Medicine, vol. 354, n. 6, Waltham, Massachusetts Medical Society, 9 febbraio 2006, pp. 636-38, DOI:10.1056/NEJMe058311, ISSN 0028-4793 (WC · ACNP), PMID 16467553.
Serebruany. (EN) Victor L. Serebruany, Selective Serotonin Reuptake Inhibitors and Increased Bleeding Risk: Are We Missing Something?, in The American Journal of Medicine, vol. 119, n. 2, Alexandria, Alliance for Academic Internal Medicine, febbraio 2006, pp. 113-16, DOI:10.1016/j.amjmed.2005.03.044, ISSN 0002-9343 (WC · ACNP), PMID 16443409.
(EN) Salvatore Gentile, Prenatal antidepressant exposure and the risk of autism spectrum disorders in children. Are we looking at the fall of Gods?, in Journal of Affective Disorders, vol. 182, 15 agosto 2015, pp. 132–137, DOI:10.1016/j.jad.2015.04.048. URL consultato il 7 giugno 2017.
(EN) Heli Malm, Alan S. Brown e Mika Gissler, Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based Study, in Journal of the American Academy of Child & Adolescent Psychiatry, vol. 55, n. 5, 1º maggio 2016, pp. 359–366, DOI:10.1016/j.jaac.2016.02.013. URL consultato il 7 giugno 2017.
MJ Owens, DL Knight e CB Nemeroff, Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine., in Biological Psychiatry, vol. 50, n. 5, 1º settembre 2001, pp. 345–50, DOI:10.1016/s0006-3223(01)01145-3, PMID 11543737.
S. Koch, KW. Perry; DL. Nelson; RG. Conway; PG. Threlkeld; FP. Bymaster, R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study., in Neuropsychopharmacology, vol. 27, n. 6, Dec 2002, pp. 949-59, DOI:10.1016/S0893-133X(02)00377-9, PMID 12464452.
C. Miguelez, I. Fernandez-Aedo, M. Torrecilla, L. Grandoso e L. Ugedo, Α2-Adrenoceptors mediate the acute inhibitory effect of fluoxetine on locus coeruleus noradrenergic neurons, in Neuropharmacology, vol. 56, 6–7, 2009, pp. 1068–73, DOI:10.1016/j.neuropharm.2009.03.004, PMID 19298831.
Pälvimäki EP, Roth BL, Majasuo H, etal, Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor, in Psychopharmacology, vol. 126, n. 3, August 1996, pp. 234–40, DOI:10.1007/BF02246453, PMID 8876023.
Pinna G, Costa E, Guidotti A, SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake, in Curr Opin Pharmacol, vol. 9, n. 1, February 2009, pp. 24–30, DOI:10.1016/j.coph.2008.12.006, PMC 2670606, PMID 19157982.
Brunton PJ, Neuroactive steroids and stress axis regulation: Pregnancy and beyond, in The Journal of Steroid Biochemistry and Molecular Biology, vol. 160, 2015, pp. 160–168, DOI:10.1016/j.jsbmb.2015.08.003, PMID 26259885.
Narita N, Hashimoto K, Tomitaka S, Minabe Y, Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain, in European Journal of Pharmacology, vol. 307, n. 1, June 1996, pp. 117–9, DOI:10.1016/0014-2999(96)00254-3, PMID 8831113.
Hashimoto K, Sigma-1 receptors and selective serotonin reuptake inhibitors: clinical implications of their relationship, in Central Nervous System Agents in Medicinal Chemistry, vol. 9, n. 3, September 2009, pp. 197–204, DOI:10.2174/1871524910909030197, PMID 20021354.
Robinson RT, Drafts BC, Fisher JL, Fluoxetine increases GABA(A) receptor activity through a novel modulatory site, in J. Pharmacol. Exp. Ther., vol. 304, n. 3, 2003, pp. 978–84, DOI:10.1124/jpet.102.044834, PMID 12604672.
Erich Gulbins, Monica Palmada, Martin Reichel, Anja Lüth, Christoph Böhmer, Davide Amato, Christian P Müller, Carsten H Tischbirek, Teja W Groemer, Ghazaleh Tabatabai, Katrin A Becker, Philipp Tripal, Sven Staedtler, Teresa F Ackermann, Johannes van Brederode, Christian Alzheimer, Michael Weller, Undine E Lang, Burkhard Kleuser, Heike Grassmé e Johannes Kornhuber, Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs, in Nature Medicine, vol. 19, June 2013, pp. 934–938, DOI:10.1038/nm.3214, PMID 23770692.
R. Brunkhorst, F. Friedlaender, N. Ferreirós, S. Schwalm, A. Koch, G. Grammatikos, S. Toennes, C. Foerch, J. Pfeilschifter e W. Pfeilschifter, Alterations of the Ceramide Metabolism in the Peri-Infarct Cortex Are Independent of the Sphingomyelinase Pathway and Not Influenced by the Acid Sphingomyelinase Inhibitor Fluoxetine, in Neural Plasticity, vol. 2015, October 2015, pp. 1–10, DOI:10.1155/2015/503079, PMC 4641186, PMID 26605090.
T. J. Steiner, F. Ahmed e L. J. Findley, S-fluoxetine in the prophylaxis of migraine: a phase II double-blind randomized placebo-controlled study, in Cephalalgia: An International Journal of Headache, vol. 18, n. 5, 1998-06, pp. 283–286, DOI:10.1046/j.1468-2982.1998.1805283.x. URL consultato il 25 maggio 2022.
Subhi Marwari e Gavin S. Dawe, (R)-fluoxetine enhances cognitive flexibility and hippocampal cell proliferation in mice, in Journal of Psychopharmacology (Oxford, England), vol. 32, n. 4, 2018-04, pp. 441–457, DOI:10.1177/0269881118754733. URL consultato il 25 maggio 2022.

europepmc.org

Stone KJ, Viera AJ e Parman CL, Off-label applications for SSRIs., in American family physician, vol. 68, n. 3, 1º agosto 2003. URL consultato il 13 dicembre 2016.

guidetopharmacology.org

Fluoxetine, su IUPHAR Guide to Pharmacology, IUPHAR. URL consultato il 10 novembre 2014.
Calcium activated chloride channel, su IUPHAR Guide to Pharmacology, IUPHAR. URL consultato il 10 novembre 2014.

jaacap.com

(EN) Heli Malm, Alan S. Brown e Mika Gissler, Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based Study, in Journal of the American Academy of Child & Adolescent Psychiatry, vol. 55, n. 5, 1º maggio 2016, pp. 359–366, DOI:10.1016/j.jaac.2016.02.013. URL consultato il 7 giugno 2017.

jad-journal.com

(EN) Salvatore Gentile, Prenatal antidepressant exposure and the risk of autism spectrum disorders in children. Are we looking at the fall of Gods?, in Journal of Affective Disorders, vol. 182, 15 agosto 2015, pp. 132–137, DOI:10.1016/j.jad.2015.04.048. URL consultato il 7 giugno 2017.

lilly.com

pi.lilly.com

FDA - EliLilly, Foglietto Illustrativo del Prozac - USA (PDF).

medicinescomplete.com

Brayfield, A, ed., Fluoxetine Hydrochloride. Martindale: The Complete Drug Reference., London, London, UK: Pharmaceutical Press, 2013.

nature.com

Erich Gulbins, Monica Palmada, Martin Reichel, Anja Lüth, Christoph Böhmer, Davide Amato, Christian P Müller, Carsten H Tischbirek, Teja W Groemer, Ghazaleh Tabatabai, Katrin A Becker, Philipp Tripal, Sven Staedtler, Teresa F Ackermann, Johannes van Brederode, Christian Alzheimer, Michael Weller, Undine E Lang, Burkhard Kleuser, Heike Grassmé e Johannes Kornhuber, Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs, in Nature Medicine, vol. 19, June 2013, pp. 934–938, DOI:10.1038/nm.3214, PMID 23770692.

nhs.uk

NHS Choices, Selective serotonin reuptake inhibitors (SSRIs) - Side effects - NHS Choices, su nhs.uk. URL consultato il 13 dicembre 2016.

nih.gov

ncbi.nlm.nih.gov

A. L. Montejo-González, G. Llorca e J. A. Izquierdo, SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients, in Journal of Sex & Marital Therapy, vol. 23, n. 3, 1º gennaio 1997, pp. 176–194, DOI:10.1080/00926239708403923. URL consultato il 13 dicembre 2016.
Sansone et al. (EN) Randy A. Sansone, Lori A. Sansone, Sertraline-induced Hyperglycemia: Case Report, in The International Journal of Psychiatry in Medicine, vol. 33, n. 1, Amityville, Baywood Publishing Company, Inc., marzo 2003, pp. 103-5, DOI:10.2190/L2M6-Y6XT-KR7U-CAVT, ISSN 0091-2174 (WC · ACNP), PMID 12906348.
Malm et al. (EN) Heli Malm, Timo Klaukka, Pertti J. Neuvonen, Risks Associated With Selective Serotonin Reuptake Inhibitors in Pregnancy, in Obstetrics & Gynecology, vol. 106, n. 6, Hagerstown, Lippincott Williams & Wilkins, dicembre 2005, pp. 1289-96, DOI:10.1097/01.AOG.0000187302.61812.53, ISSN 0029-7844 (WC · ACNP), PMID 16319254.
Chambers et al. (EN) Christina D. Chambers et al., Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn, in The New England Journal of Medicine, vol. 354, n. 6, Waltham, Massachusetts Medical Society, 9 febbraio 2006, pp. 579-87, DOI:10.1056/NEJMoa052744, ISSN 0028-4793 (WC · ACNP), PMID 16467545.
Mills. (EN) James L. Mills, Depressing Observations on the Use of Selective Serotonin-Reuptake Inhibitors during Pregnancy, in The New England Journal of Medicine, vol. 354, n. 6, Waltham, Massachusetts Medical Society, 9 febbraio 2006, pp. 636-38, DOI:10.1056/NEJMe058311, ISSN 0028-4793 (WC · ACNP), PMID 16467553.
Serebruany. (EN) Victor L. Serebruany, Selective Serotonin Reuptake Inhibitors and Increased Bleeding Risk: Are We Missing Something?, in The American Journal of Medicine, vol. 119, n. 2, Alexandria, Alliance for Academic Internal Medicine, febbraio 2006, pp. 113-16, DOI:10.1016/j.amjmed.2005.03.044, ISSN 0002-9343 (WC · ACNP), PMID 16443409.
MJ Owens, DL Knight e CB Nemeroff, Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine., in Biological Psychiatry, vol. 50, n. 5, 1º settembre 2001, pp. 345–50, DOI:10.1016/s0006-3223(01)01145-3, PMID 11543737.
S. Koch, KW. Perry; DL. Nelson; RG. Conway; PG. Threlkeld; FP. Bymaster, R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study., in Neuropsychopharmacology, vol. 27, n. 6, Dec 2002, pp. 949-59, DOI:10.1016/S0893-133X(02)00377-9, PMID 12464452.
C. Miguelez, I. Fernandez-Aedo, M. Torrecilla, L. Grandoso e L. Ugedo, Α2-Adrenoceptors mediate the acute inhibitory effect of fluoxetine on locus coeruleus noradrenergic neurons, in Neuropharmacology, vol. 56, 6–7, 2009, pp. 1068–73, DOI:10.1016/j.neuropharm.2009.03.004, PMID 19298831.
Pälvimäki EP, Roth BL, Majasuo H, etal, Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor, in Psychopharmacology, vol. 126, n. 3, August 1996, pp. 234–40, DOI:10.1007/BF02246453, PMID 8876023.
Pinna G, Costa E, Guidotti A, SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake, in Curr Opin Pharmacol, vol. 9, n. 1, February 2009, pp. 24–30, DOI:10.1016/j.coph.2008.12.006, PMC 2670606, PMID 19157982.
Brunton PJ, Neuroactive steroids and stress axis regulation: Pregnancy and beyond, in The Journal of Steroid Biochemistry and Molecular Biology, vol. 160, 2015, pp. 160–168, DOI:10.1016/j.jsbmb.2015.08.003, PMID 26259885.
Narita N, Hashimoto K, Tomitaka S, Minabe Y, Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain, in European Journal of Pharmacology, vol. 307, n. 1, June 1996, pp. 117–9, DOI:10.1016/0014-2999(96)00254-3, PMID 8831113.
Hashimoto K, Sigma-1 receptors and selective serotonin reuptake inhibitors: clinical implications of their relationship, in Central Nervous System Agents in Medicinal Chemistry, vol. 9, n. 3, September 2009, pp. 197–204, DOI:10.2174/1871524910909030197, PMID 20021354.
Robinson RT, Drafts BC, Fisher JL, Fluoxetine increases GABA(A) receptor activity through a novel modulatory site, in J. Pharmacol. Exp. Ther., vol. 304, n. 3, 2003, pp. 978–84, DOI:10.1124/jpet.102.044834, PMID 12604672.
Erich Gulbins, Monica Palmada, Martin Reichel, Anja Lüth, Christoph Böhmer, Davide Amato, Christian P Müller, Carsten H Tischbirek, Teja W Groemer, Ghazaleh Tabatabai, Katrin A Becker, Philipp Tripal, Sven Staedtler, Teresa F Ackermann, Johannes van Brederode, Christian Alzheimer, Michael Weller, Undine E Lang, Burkhard Kleuser, Heike Grassmé e Johannes Kornhuber, Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs, in Nature Medicine, vol. 19, June 2013, pp. 934–938, DOI:10.1038/nm.3214, PMID 23770692.
R. Brunkhorst, F. Friedlaender, N. Ferreirós, S. Schwalm, A. Koch, G. Grammatikos, S. Toennes, C. Foerch, J. Pfeilschifter e W. Pfeilschifter, Alterations of the Ceramide Metabolism in the Peri-Infarct Cortex Are Independent of the Sphingomyelinase Pathway and Not Influenced by the Acid Sphingomyelinase Inhibitor Fluoxetine, in Neural Plasticity, vol. 2015, October 2015, pp. 1–10, DOI:10.1155/2015/503079, PMC 4641186, PMID 26605090.

pubmed.ncbi.nlm.nih.gov

T. J. Steiner, F. Ahmed e L. J. Findley, S-fluoxetine in the prophylaxis of migraine: a phase II double-blind randomized placebo-controlled study, in Cephalalgia: An International Journal of Headache, vol. 18, n. 5, 1998-06, pp. 283–286, DOI:10.1046/j.1468-2982.1998.1805283.x. URL consultato il 25 maggio 2022.
Subhi Marwari e Gavin S. Dawe, (R)-fluoxetine enhances cognitive flexibility and hippocampal cell proliferation in mice, in Journal of Psychopharmacology (Oxford, England), vol. 32, n. 4, 2018-04, pp. 441–457, DOI:10.1177/0269881118754733. URL consultato il 25 maggio 2022.

oadoi.org

Gülseren et al. (EN) Leyla Gülseren, Seref Gülseren, Zeliha Hekimsoy, Levent Mete, Comparison of Fluoxetine and Paroxetine in Type II Diabetes Mellitus Patients, in Archives of Medical Research, vol. 36, n. 2, Città del Messico, Instituto Mexicano del Seguro Social, 4 marzo 2005, pp. 159-65, DOI:10.1016/j.arcmed.2004.12.018, ISSN 0188-4409 (WC · ACNP).
Sansone et al. (EN) Randy A. Sansone, Lori A. Sansone, Sertraline-induced Hyperglycemia: Case Report, in The International Journal of Psychiatry in Medicine, vol. 33, n. 1, Amityville, Baywood Publishing Company, Inc., marzo 2003, pp. 103-5, DOI:10.2190/L2M6-Y6XT-KR7U-CAVT, ISSN 0091-2174 (WC · ACNP), PMID 12906348.
Kirby et al. (EN) Dianne Kirby, Susan Harrigan, David Ames, Hyponatraemia in Elderly Psychiatric Patients Treated with Selective Serotonin Reuptake Inhibitors and Venlafaxine: A Retrospective Controlled Study in an Inpatient Unit, in International Journal of Geriatric Psychiatry, vol. 17, n. 3, Hoboken, John Wiley & Sons Ltd, marzo 2002, pp. 231-37, DOI:10.1002/gps.591, ISSN 1099-1166 (WC · ACNP).
Malm et al. (EN) Heli Malm, Timo Klaukka, Pertti J. Neuvonen, Risks Associated With Selective Serotonin Reuptake Inhibitors in Pregnancy, in Obstetrics & Gynecology, vol. 106, n. 6, Hagerstown, Lippincott Williams & Wilkins, dicembre 2005, pp. 1289-96, DOI:10.1097/01.AOG.0000187302.61812.53, ISSN 0029-7844 (WC · ACNP), PMID 16319254.
Chambers et al. (EN) Christina D. Chambers et al., Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn, in The New England Journal of Medicine, vol. 354, n. 6, Waltham, Massachusetts Medical Society, 9 febbraio 2006, pp. 579-87, DOI:10.1056/NEJMoa052744, ISSN 0028-4793 (WC · ACNP), PMID 16467545.
Mills. (EN) James L. Mills, Depressing Observations on the Use of Selective Serotonin-Reuptake Inhibitors during Pregnancy, in The New England Journal of Medicine, vol. 354, n. 6, Waltham, Massachusetts Medical Society, 9 febbraio 2006, pp. 636-38, DOI:10.1056/NEJMe058311, ISSN 0028-4793 (WC · ACNP), PMID 16467553.
Serebruany. (EN) Victor L. Serebruany, Selective Serotonin Reuptake Inhibitors and Increased Bleeding Risk: Are We Missing Something?, in The American Journal of Medicine, vol. 119, n. 2, Alexandria, Alliance for Academic Internal Medicine, febbraio 2006, pp. 113-16, DOI:10.1016/j.amjmed.2005.03.044, ISSN 0002-9343 (WC · ACNP), PMID 16443409.
MJ Owens, DL Knight e CB Nemeroff, Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine., in Biological Psychiatry, vol. 50, n. 5, 1º settembre 2001, pp. 345–50, DOI:10.1016/s0006-3223(01)01145-3, PMID 11543737.
S. Koch, KW. Perry; DL. Nelson; RG. Conway; PG. Threlkeld; FP. Bymaster, R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study., in Neuropsychopharmacology, vol. 27, n. 6, Dec 2002, pp. 949-59, DOI:10.1016/S0893-133X(02)00377-9, PMID 12464452.
C. Miguelez, I. Fernandez-Aedo, M. Torrecilla, L. Grandoso e L. Ugedo, Α2-Adrenoceptors mediate the acute inhibitory effect of fluoxetine on locus coeruleus noradrenergic neurons, in Neuropharmacology, vol. 56, 6–7, 2009, pp. 1068–73, DOI:10.1016/j.neuropharm.2009.03.004, PMID 19298831.
Brunton PJ, Neuroactive steroids and stress axis regulation: Pregnancy and beyond, in The Journal of Steroid Biochemistry and Molecular Biology, vol. 160, 2015, pp. 160–168, DOI:10.1016/j.jsbmb.2015.08.003, PMID 26259885.
Narita N, Hashimoto K, Tomitaka S, Minabe Y, Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain, in European Journal of Pharmacology, vol. 307, n. 1, June 1996, pp. 117–9, DOI:10.1016/0014-2999(96)00254-3, PMID 8831113.
Hashimoto K, Sigma-1 receptors and selective serotonin reuptake inhibitors: clinical implications of their relationship, in Central Nervous System Agents in Medicinal Chemistry, vol. 9, n. 3, September 2009, pp. 197–204, DOI:10.2174/1871524910909030197, PMID 20021354.

springer.de

link.springer.de

Pälvimäki EP, Roth BL, Majasuo H, etal, Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor, in Psychopharmacology, vol. 126, n. 3, August 1996, pp. 234–40, DOI:10.1007/BF02246453, PMID 8876023.

unibo.it

acnpsearch.unibo.it

Gülseren et al. (EN) Leyla Gülseren, Seref Gülseren, Zeliha Hekimsoy, Levent Mete, Comparison of Fluoxetine and Paroxetine in Type II Diabetes Mellitus Patients, in Archives of Medical Research, vol. 36, n. 2, Città del Messico, Instituto Mexicano del Seguro Social, 4 marzo 2005, pp. 159-65, DOI:10.1016/j.arcmed.2004.12.018, ISSN 0188-4409 (WC · ACNP).
Sansone et al. (EN) Randy A. Sansone, Lori A. Sansone, Sertraline-induced Hyperglycemia: Case Report, in The International Journal of Psychiatry in Medicine, vol. 33, n. 1, Amityville, Baywood Publishing Company, Inc., marzo 2003, pp. 103-5, DOI:10.2190/L2M6-Y6XT-KR7U-CAVT, ISSN 0091-2174 (WC · ACNP), PMID 12906348.
Kirby et al. (EN) Dianne Kirby, Susan Harrigan, David Ames, Hyponatraemia in Elderly Psychiatric Patients Treated with Selective Serotonin Reuptake Inhibitors and Venlafaxine: A Retrospective Controlled Study in an Inpatient Unit, in International Journal of Geriatric Psychiatry, vol. 17, n. 3, Hoboken, John Wiley & Sons Ltd, marzo 2002, pp. 231-37, DOI:10.1002/gps.591, ISSN 1099-1166 (WC · ACNP).
Malm et al. (EN) Heli Malm, Timo Klaukka, Pertti J. Neuvonen, Risks Associated With Selective Serotonin Reuptake Inhibitors in Pregnancy, in Obstetrics & Gynecology, vol. 106, n. 6, Hagerstown, Lippincott Williams & Wilkins, dicembre 2005, pp. 1289-96, DOI:10.1097/01.AOG.0000187302.61812.53, ISSN 0029-7844 (WC · ACNP), PMID 16319254.
Chambers et al. (EN) Christina D. Chambers et al., Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn, in The New England Journal of Medicine, vol. 354, n. 6, Waltham, Massachusetts Medical Society, 9 febbraio 2006, pp. 579-87, DOI:10.1056/NEJMoa052744, ISSN 0028-4793 (WC · ACNP), PMID 16467545.
Mills. (EN) James L. Mills, Depressing Observations on the Use of Selective Serotonin-Reuptake Inhibitors during Pregnancy, in The New England Journal of Medicine, vol. 354, n. 6, Waltham, Massachusetts Medical Society, 9 febbraio 2006, pp. 636-38, DOI:10.1056/NEJMe058311, ISSN 0028-4793 (WC · ACNP), PMID 16467553.
Serebruany. (EN) Victor L. Serebruany, Selective Serotonin Reuptake Inhibitors and Increased Bleeding Risk: Are We Missing Something?, in The American Journal of Medicine, vol. 119, n. 2, Alexandria, Alliance for Academic Internal Medicine, febbraio 2006, pp. 113-16, DOI:10.1016/j.amjmed.2005.03.044, ISSN 0002-9343 (WC · ACNP), PMID 16443409.

web.archive.org

Hines RN, Adams J, Buck GM, Faber W, Holson JF, Jacobson SW, Keszler M, McMartin K, Segraves RT, Singer LT, Sipes IG, Williams PL., NTP-CERHR Expert panel report on the reproductive and developmental toxicity of fluoxetine (PDF) (archiviato dall'url originale il 16 novembre 2006).
Roth, BL e Driscol, J, PDSP K_i Database, su Psychoactive Drug Screening Program (PDSP), University of North Carolina at Chapel Hill and the United States National Institute of Mental Health, 12 gennaio 2011. URL consultato il 24 giugno 2013 (archiviato dall'url originale l'8 novembre 2013).

webcitation.org

(EN) Fluoxetine Related Compound B, su sigmaaldrich.com, Sigma Aldrich. URL consultato il 15 luglio 2015 (archiviato dall'url originale il 15 luglio 2015).

worldcat.org

Gülseren et al. (EN) Leyla Gülseren, Seref Gülseren, Zeliha Hekimsoy, Levent Mete, Comparison of Fluoxetine and Paroxetine in Type II Diabetes Mellitus Patients, in Archives of Medical Research, vol. 36, n. 2, Città del Messico, Instituto Mexicano del Seguro Social, 4 marzo 2005, pp. 159-65, DOI:10.1016/j.arcmed.2004.12.018, ISSN 0188-4409 (WC · ACNP).
Sansone et al. (EN) Randy A. Sansone, Lori A. Sansone, Sertraline-induced Hyperglycemia: Case Report, in The International Journal of Psychiatry in Medicine, vol. 33, n. 1, Amityville, Baywood Publishing Company, Inc., marzo 2003, pp. 103-5, DOI:10.2190/L2M6-Y6XT-KR7U-CAVT, ISSN 0091-2174 (WC · ACNP), PMID 12906348.
Kirby et al. (EN) Dianne Kirby, Susan Harrigan, David Ames, Hyponatraemia in Elderly Psychiatric Patients Treated with Selective Serotonin Reuptake Inhibitors and Venlafaxine: A Retrospective Controlled Study in an Inpatient Unit, in International Journal of Geriatric Psychiatry, vol. 17, n. 3, Hoboken, John Wiley & Sons Ltd, marzo 2002, pp. 231-37, DOI:10.1002/gps.591, ISSN 1099-1166 (WC · ACNP).
Malm et al. (EN) Heli Malm, Timo Klaukka, Pertti J. Neuvonen, Risks Associated With Selective Serotonin Reuptake Inhibitors in Pregnancy, in Obstetrics & Gynecology, vol. 106, n. 6, Hagerstown, Lippincott Williams & Wilkins, dicembre 2005, pp. 1289-96, DOI:10.1097/01.AOG.0000187302.61812.53, ISSN 0029-7844 (WC · ACNP), PMID 16319254.
Chambers et al. (EN) Christina D. Chambers et al., Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn, in The New England Journal of Medicine, vol. 354, n. 6, Waltham, Massachusetts Medical Society, 9 febbraio 2006, pp. 579-87, DOI:10.1056/NEJMoa052744, ISSN 0028-4793 (WC · ACNP), PMID 16467545.
Mills. (EN) James L. Mills, Depressing Observations on the Use of Selective Serotonin-Reuptake Inhibitors during Pregnancy, in The New England Journal of Medicine, vol. 354, n. 6, Waltham, Massachusetts Medical Society, 9 febbraio 2006, pp. 636-38, DOI:10.1056/NEJMe058311, ISSN 0028-4793 (WC · ACNP), PMID 16467553.
Serebruany. (EN) Victor L. Serebruany, Selective Serotonin Reuptake Inhibitors and Increased Bleeding Risk: Are We Missing Something?, in The American Journal of Medicine, vol. 119, n. 2, Alexandria, Alliance for Academic Internal Medicine, febbraio 2006, pp. 113-16, DOI:10.1016/j.amjmed.2005.03.044, ISSN 0002-9343 (WC · ACNP), PMID 16443409.
Carla Gasbarri, Fondamenti di chimica organica, 4. ed. it. condotta sulla 7. ed. americana, Zanichelli, 2011, ISBN 978-88-08-06131-7, OCLC 848799230. URL consultato il 25 maggio 2022.